As of January 2025 Genmab has a market cap of NZ$23.00 Billion. This makes Genmab the world's 1351th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 14th, 2025 the market cap of Genmab was reported to be: